Why insurers are slow to cover Ozempic, Wegovy and other weight-loss drugs : The Indicator from Planet Money Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.

Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)

For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.

Music by
Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.

Who can and cannot get weight-loss drugs

Who can and cannot get weight-loss drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/1197958695/1217127183" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Sean Gallup/Getty Images
Photo by Sean Gallup/Getty Images
Sean Gallup/Getty Images

Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.

Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)

For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.

Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.